| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $193K | — | — |
| Cost of Revenue | $203K | — | — |
| Gross Profit | -$10K | — | — |
| R&D Expense | $137K | — | +67.2% |
| SG&A Expense | $5.1M | — | +270.4% |
| Operating Income | -$86.3M | — | -4166.9% |
| Pre-tax Income | -$86.2M | — | -4571.1% |
| Net Income | -$86.2M | — | -4571.1% |
| EPS (Basic) | -$1.19 | — | -103.1% |
| EPS (Diluted) | -$1.19 | — | -103.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.3M | +18.7% | +3.6% |
| Inventory | $458K | -29.1% | -77.7% |
| Current Assets | $18.4M | -2.7% | +29.0% |
| Total Assets | $181.0M | -32.7% | +856.9% |
| Current Liabilities | $2.2M | -52.7% | -74.3% |
| Total Liabilities | $2.2M | -52.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.7M | — | -9.2% |
| Investing Cash Flow | $9.3M | — | +2061.1% |
| Financing Cash Flow | -$4.7M | — | -133.5% |
| -74.7% |
| Stockholders' Equity | $178.8M | -32.4% | +1664.0% |